BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 35829804)

  • 21. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of latent biomarkers in connection with progression and prognosis in oral cancer by comprehensive bioinformatics analysis.
    Reyimu A; Chen Y; Song X; Zhou W; Dai J; Jiang F
    World J Surg Oncol; 2021 Aug; 19(1):240. PubMed ID: 34384424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ferroptosis-related long non-coding RNA signature predicts the prognosis of bladder cancer.
    Hou J; Lu Z; Cheng X; Dong R; Jiang Y; Wu G; Qu G; Xu Y
    BMC Cancer; 2022 Jun; 22(1):719. PubMed ID: 35768833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploration of key ferroptosis-related genes and immune infiltration in Crohn's disease using bioinformatics.
    Tang X; Hu W; You W; Fang T
    Sci Rep; 2023 Aug; 13(1):12769. PubMed ID: 37550393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of ferroptosis-related genes and their methylation in AML.
    Zhou F; Chen B
    Hematology; 2021 Dec; 26(1):919-930. PubMed ID: 34789073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Novel Ferroptosis-Related Gene Signature to Predict Prognosis in Patients with Head and Neck Squamous Cell Carcinoma.
    Xu L; Li YY; Zhang YC; Wu YX; Guo DD; Long D; Liu ZH
    Dis Markers; 2021; 2021():5759927. PubMed ID: 34853622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and Validation of a Novel Ferroptosis-Related Gene Signature for Predicting Prognosis and the Immune Microenvironment in Gastric Cancer.
    Wang F; Chen C; Chen WP; Li ZL; Cheng H
    Biomed Res Int; 2021; 2021():6014202. PubMed ID: 34708125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
    Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
    Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of potential ferroptosis-associated biomarkers in rheumatoid arthritis.
    He X; Zhang J; Gong M; Gu Y; Dong B; Pang X; Zhang C; Cui Y
    Front Immunol; 2023; 14():1197275. PubMed ID: 37492576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioinformatics analysis identified MMP14 and COL12A1 as immune-related biomarkers associated with pancreatic adenocarcinoma prognosis.
    Li Y; Su Z; Wei B; Qin M; Liang Z
    Math Biosci Eng; 2021 Jun; 18(5):5921-5942. PubMed ID: 34517516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
    Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
    Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Remarkable immune and clinical value of novel ferroptosis-related genes in glioma.
    Gao X; Zhao J; Jia L; Zhang Q
    Sci Rep; 2022 Jul; 12(1):12854. PubMed ID: 35896732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel ferroptosis-related genes model for prognosis prediction of lung adenocarcinoma.
    Li F; Ge D; Sun SL
    BMC Pulm Med; 2021 Jul; 21(1):229. PubMed ID: 34256754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploration and validation of the effects of robust co-expressed immune-related genes on immune infiltration patterns and prognosis in laryngeal cancer.
    Zeng H; Huang Y; Chen L; Li H; Ma X
    Int Immunopharmacol; 2020 Aug; 85():106622. PubMed ID: 32485354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioinformatics analyses and experimental validation of ferroptosis-related genes in bronchopulmonary dysplasia pathogenesis.
    Luo Y; Zhang Z; Xi S; Li T
    PLoS One; 2024; 19(6):e0291583. PubMed ID: 38875180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Computational analysis for identification of early diagnostic biomarkers and prognostic biomarkers of liver cancer based on GEO and TCGA databases and studies on pathways and biological functions affecting the survival time of liver cancer.
    Gao S; Gang J; Yu M; Xin G; Tan H
    BMC Cancer; 2021 Jul; 21(1):791. PubMed ID: 34238253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma.
    Li J; Liu X; Cui Z; Han G
    Med Sci Monit; 2020 Jun; 26():e922070. PubMed ID: 32578582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and validation of a ferroptosis-related prognostic model for the prediction of progression-free survival and immune microenvironment in patients with papillary thyroid carcinoma.
    Huang Y; Xie Z; Li X; Chen W; He Y; Wu S; Li X; Hou B; Sun J; Wang S; He Y; Jiang H; Lun Y; Zhang J
    Int Immunopharmacol; 2021 Dec; 101(Pt A):108156. PubMed ID: 34624650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal tubular gen e biomarkers identification based on immune infiltrates in focal segmental glomerulosclerosis.
    Bai J; Pu X; Zhang Y; Dai E
    Ren Fail; 2022 Dec; 44(1):966-986. PubMed ID: 35713363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma.
    Li Y; Zhu YY; Dai GP; Wu DJ; Gao ZZ; Zhang L; Fan YH
    Math Biosci Eng; 2019 Nov; 17(1):910-927. PubMed ID: 31731384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.